Uncover key drivers, emerging technologies, and competitive movements shaping the fetal bovine serum market from 2025–2034 with trusted insights from The Business Research Company
What CAGR And Valuation Are Anticipated For The Fetal Bovine Serum Market By The End Of 2029?
The fetal bovine serum market has shown consistent growth over recent years. Its value is anticipated to rise from $1.02 billion in 2024 to $1.06 billion in 2025, achieving a compound annual growth rate (CAGR) of 4.6%. Key contributors to this past growth include the expansion of the biopharmaceutical industry, the rise in cell-based therapies, and specific quality and consistency requirements.
The fetal bovine serum market is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $1.31 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.4%. This anticipated growth during the forecast period stems from factors such as the rising uptake of cell therapies, the development of advanced therapeutics, an emphasis on animal-free alternatives, and strategic partnerships between suppliers and customers. Key trends expected within this period encompass a strong focus on quality and traceability, increased global collaboration and partnerships, strategic mergers and acquisitions, the offering of customized fetal bovine serum products, and adherence to regulatory compliance and ethical sourcing practices.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4109&type=smp
Which Business Drivers Are Underpinning The Growth Of The Fetal Bovine Serum Market?
The anticipated surge in biopharmaceutical demand is projected to fuel the expansion of the fetal bovine serum market throughout the forecast period. Biopharmaceuticals are medical products obtained from biological origins like animals, humans, and microorganisms through biotechnological processes. Fetal bovine serum (FBS) serves as the predominant alternative for animal cell culture media. Pharmaceutical companies, diagnostic labs, and scientists significantly depend on FBS to meet a substantial portion of their cell culture needs in biologics investigations. Notably, in 2022, ProClinical Limited, a lifesciences service and consulting firm located in the UK, reported combined sales of US$36.15mn for its pharmaceutical and vaccine divisions, marking an 11% year-over-year increase. Consequently, this escalating demand for biopharmaceuticals is a key driver for the growth of the fetal bovine serum market.
What Are The Principal Segment Types In The Fetal Bovine Serum Market?
The fetal bovine serum market covered in this report is segmented –
1) By Product: Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum, Exosome Depleted, Stem Cell, Other Products
2) By Application: Drug Discovery, Cell Culture Media, In Vitro Fertilization, Human And Animal Vaccine Production, Diagnostics, Other Applications
3) By End-User: Research And Academic Institutes, Biotechnology And Pharmaceutical Industry, Other End-Users
Subsegments:
1) By Charcoal Stripped: Standard Charcoal Stripped FBS, Heat-Inactivated Charcoal Stripped FBS
2) By Chromatographic: Ion Exchange Chromatography Purified FBS, Affinity Chromatography Purified FBS
3) By Dialyzed Fetal Bovine Serum: Standard Dialyzed FBS, Heat-Inactivated Dialyzed FBS
4) By Exosome Depleted: Standard Exosome Depleted FBS, Heat-Inactivated Exosome Depleted FBS
5) By Stem Cell: Stem Cell Grade FBS, Knockout Serum Replacement
6) By Other Products: Serum from Specific Animal Breeds, Custom-Processed FBS
How Are Industry Trends Steering The Expansion Of The Fetal Bovine Serum Market?
A prominent trend gaining traction in the fetal bovine serum market is the rising number of collaborations between companies and research institutions. Key players in the industry are entering into partnerships to boost their production capabilities, expand their market share, and innovate new products. For example, US-based GE Healthcare teamed up with New Zealand-based Oritain to develop an independent test capable of verifying the country of origin of fetal bovine serum (FBS), a solution beneficial for biomanufacturing entities since FBS from different countries carries varying risk levels for virus contamination.
Which Companies Are Contributing Significantly To The Fetal Bovine Serum Market Growth?
Major companies operating in the fetal bovine serum market include Thermo Fisher Scientific Inc., Merck KGaA, Corning Incorporated, Cytiva, VWR International, Sartorius AG, Bio-Techne Corporation, Atlas Biologicals Inc., R&D Systems Inc., Atlanta Biologicals Inc., Cyagen Biosciences, GenClone Inc., Gemini Bio-Products, Access Biologicals LLC, Nucleus Biologics, ZenBio Inc., Biowest, Bovogen Biologicals Pty Ltd., TCS Biosciences Ltd., J R Scientific Inc., Rocky Mountain Biologicals Inc., Tissue Culture Biologicals, Moregate Biotech, Cell Applications Inc., Altogen Biosystems, Axil Scientific Pte Ltd., Animal Technologies Inc., PAN- Biotech, PAA Laboratories GmbH, Peak Serum Inc.
Download The Full Report Here:
https://www.thebusinessresearchcompany.com/report/fetal-bovine-serum-global-market-report
Which Region Offers The Most Opportunity For Fetal Bovine Serum Market Expansion?
North America was the largest region in the fetal bovine serum market in 2024. Asia-Pacific recorded the fastest growth during the forecast period. The regions covered in the fetal bovine serum market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=4109&type=smp
Browse Through More Reports Similar to the Global Fetal Bovine Serum Market 2025, By The Business Research Company
Dialysis Devices And Equipment Global Market Report 2025
Fetal And Neonatal Monitoring Devices Global Market Report 2025
Patient Monitoring Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/patient-monitoring-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
